Dose-finding study of K-877 in combination with pitavastatin

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221795

Enrollment

168

Registered

2012-05-22

Start date

2012-05-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

investigational material(s) Generic name etc : K-877 INN of investigational material : Therapeutic category code : 218 Agents for hyperlipidemias Dosage and Administration for Investigational materia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dyslipidemia with high TG and high non-HDL-C

Exclusion criteria

Exclusion criteria: The subjects whom administration of pitavastatin are contraindicated for The subjects who need to be taken any other anti lipidemic agent

Design outcomes

Primary

Measure	Time frame
TG percent change at the completion of treatment Central laboratory test	—

Secondary

Measure	Time frame
Percent changes of other lipid parameters at the completion of treatment Central laboratory test	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026